Key information relating to the preferential rights issue to be carried out by PCI Biotech Holding ASA

Date on which the terms and conditions of the preferential rights issue were announced: 24 august 2018
Last day including right: 14 September 2018
Ex-date: 17 September 2018
Record Date: 18 September 2018
Date of approval: 14 September 2018
Maximum number of new shares: 12,000,000
Subscription price: 30
Will the rights be listed: yes

This information is published in accordance with the requirements of the Continuing Obligations.